BlackRock’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.3M Sell
1,358,781
-257,020
-16% -$4.79M ﹤0.01% 2829
2025
Q1
$29.3M Sell
1,615,801
-35,081
-2% -$636K ﹤0.01% 2686
2024
Q4
$36M Buy
1,650,882
+6,063
+0.4% +$132K ﹤0.01% 2633
2024
Q3
$45M Buy
1,644,819
+41,272
+3% +$1.13M ﹤0.01% 2499
2024
Q2
$41.5M Buy
1,603,547
+1,556,932
+3,340% +$40.3M ﹤0.01% 2497
2024
Q1
$1.4M Buy
46,615
+14,309
+44% +$429K ﹤0.01% 4051
2023
Q4
$336K Buy
32,306
+155
+0.5% +$1.61K ﹤0.01% 4448
2023
Q3
$440K Buy
32,151
+9,390
+41% +$128K ﹤0.01% 4395
2023
Q2
$276K Sell
22,761
-6,362
-22% -$77.2K ﹤0.01% 4566
2023
Q1
$370K Buy
29,123
+183
+0.6% +$2.33K ﹤0.01% 4526
2022
Q4
$183K Sell
28,940
-17,178
-37% -$109K ﹤0.01% 4794
2022
Q3
$1.04M Sell
46,118
-3,592
-7% -$81.1K ﹤0.01% 4377
2022
Q2
$955K Sell
49,710
-83,859
-63% -$1.61M ﹤0.01% 4462
2022
Q1
$6.2M Sell
133,569
-1,975
-1% -$91.6K ﹤0.01% 3760
2021
Q4
$9.61M Sell
135,544
-2,934
-2% -$208K ﹤0.01% 3632
2021
Q3
$16.1M Buy
138,478
+5,534
+4% +$645K ﹤0.01% 3370
2021
Q2
$20.8M Buy
132,944
+11,075
+9% +$1.73M ﹤0.01% 3217
2021
Q1
$23.1M Buy
121,869
+9,278
+8% +$1.76M ﹤0.01% 3055
2020
Q4
$14.1M Buy
112,591
+2,128
+2% +$267K ﹤0.01% 3123
2020
Q3
$12M Buy
110,463
+10,374
+10% +$1.13M ﹤0.01% 3048
2020
Q2
$12M Sell
100,089
-1,204
-1% -$145K ﹤0.01% 3022
2020
Q1
$10.2M Sell
101,293
-2,363
-2% -$237K ﹤0.01% 2939
2019
Q4
$25.1M Buy
103,656
+81
+0.1% +$19.6K ﹤0.01% 2720
2019
Q3
$17M Buy
103,575
+2,111
+2% +$347K ﹤0.01% 2885
2019
Q2
$23.9M Buy
101,464
+30,504
+43% +$7.2M ﹤0.01% 2726
2019
Q1
$18.7M Buy
70,960
+36,186
+104% +$9.54M ﹤0.01% 2763
2018
Q4
$3.17M Buy
34,774
+24,047
+224% +$2.19M ﹤0.01% 3504
2018
Q3
$2.06M Buy
10,727
+4,477
+72% +$861K ﹤0.01% 3709
2018
Q2
$1.35M Buy
+6,250
New +$1.35M ﹤0.01% 3806